Search

Jerome D. Goldberg

Examiner (ID: 7239)

Most Active Art Unit
1205
Art Unit(s)
1202, 1201, 1302, 1205, 1614, 1802, 1803
Total Applications
2122
Issued Applications
1408
Pending Applications
76
Abandoned Applications
638

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4075348 [patent_doc_number] => 05965606 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Methods of treatment with compounds having RAR.sub..alpha. receptor specific or selective activity' [patent_app_type] => 1 [patent_app_number] => 8/580553 [patent_app_country] => US [patent_app_date] => 1995-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 26413 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965606.pdf [firstpage_image] =>[orig_patent_app_number] => 580553 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/580553
Methods of treatment with compounds having RAR.sub..alpha. receptor specific or selective activity Dec 28, 1995 Issued
08/578715 AGENT FOR TREATING URINARY OUTLET OBSTRUCTION ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Dec 28, 1995 Abandoned
08/573811 TREATMENT OF ACUTE LEUKEMIA WITH INTERLEUKIN-10 Dec 17, 1995 Abandoned
Array ( [id] => 3732138 [patent_doc_number] => 05665711 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Antitumor composition for oral administration' [patent_app_type] => 1 [patent_app_number] => 8/570978 [patent_app_country] => US [patent_app_date] => 1995-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4408 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665711.pdf [firstpage_image] =>[orig_patent_app_number] => 570978 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/570978
Antitumor composition for oral administration Dec 11, 1995 Issued
Array ( [id] => 3733159 [patent_doc_number] => 05665780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Reversal of multi-drug resistance by tetraarylethylenes' [patent_app_type] => 1 [patent_app_number] => 8/568067 [patent_app_country] => US [patent_app_date] => 1995-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3082 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665780.pdf [firstpage_image] =>[orig_patent_app_number] => 568067 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/568067
Reversal of multi-drug resistance by tetraarylethylenes Dec 5, 1995 Issued
Array ( [id] => 3626276 [patent_doc_number] => 05621001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Methods for administration of taxol' [patent_app_type] => 1 [patent_app_number] => 8/559890 [patent_app_country] => US [patent_app_date] => 1995-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7684 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621001.pdf [firstpage_image] =>[orig_patent_app_number] => 559890 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/559890
Methods for administration of taxol Nov 19, 1995 Issued
08/560862 EPINEPHRINE AS INHIBITOR OF CANCEROUS TUMORS Nov 19, 1995 Abandoned
08/560626 COMPONDS WITH CHELATION AFFINITY AND SELECTIVITY FOR FIRST TRANSITION SERIES ELEMENTS: USE IN MEDICAL THERAPY AND DIAGNOSIS Nov 19, 1995 Abandoned
08/554935 CARCINOSTATIC SUBSTANCE FOR COMPATIBLE ADMINISTRATION, PROCESS OF ADMINISTRATING SAME AND PROCESS OF RAPIDLY INSPECTING SAME Nov 8, 1995 Abandoned
Array ( [id] => 3992343 [patent_doc_number] => 05891864 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Anti-cancer compositions' [patent_app_type] => 1 [patent_app_number] => 8/552615 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 59 [patent_no_of_words] => 9149 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891864.pdf [firstpage_image] =>[orig_patent_app_number] => 552615 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/552615
Anti-cancer compositions Nov 2, 1995 Issued
Array ( [id] => 3809106 [patent_doc_number] => 05709853 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Method of treatment of atopic disease' [patent_app_type] => 1 [patent_app_number] => 8/525755 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1534 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/709/05709853.pdf [firstpage_image] =>[orig_patent_app_number] => 525755 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/525755
Method of treatment of atopic disease Nov 2, 1995 Issued
Array ( [id] => 4201721 [patent_doc_number] => 06077545 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Process and composition for therapeutic cisplatin (CDDP)' [patent_app_type] => 1 [patent_app_number] => 8/550086 [patent_app_country] => US [patent_app_date] => 1995-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4984 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077545.pdf [firstpage_image] =>[orig_patent_app_number] => 550086 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/550086
Process and composition for therapeutic cisplatin (CDDP) Oct 29, 1995 Issued
Array ( [id] => 3872707 [patent_doc_number] => 05763488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Methods and compositions using butyrate esters of threitol' [patent_app_type] => 1 [patent_app_number] => 8/550453 [patent_app_country] => US [patent_app_date] => 1995-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4304 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763488.pdf [firstpage_image] =>[orig_patent_app_number] => 550453 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/550453
Methods and compositions using butyrate esters of threitol Oct 29, 1995 Issued
Array ( [id] => 3621996 [patent_doc_number] => 05641803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-24 [patent_title] => 'Methods for administration of taxol' [patent_app_type] => 1 [patent_app_number] => 8/544594 [patent_app_country] => US [patent_app_date] => 1995-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7680 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/641/05641803.pdf [firstpage_image] =>[orig_patent_app_number] => 544594 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/544594
Methods for administration of taxol Oct 17, 1995 Issued
08/544642 ANTIBOTIC STALOBACINS Oct 17, 1995 Abandoned
08/464768 CANCER TREATMENT AND METASTASIS PREVENTION Oct 12, 1995 Abandoned
Array ( [id] => 3729033 [patent_doc_number] => 05652234 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => '3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent' [patent_app_type] => 1 [patent_app_number] => 8/513803 [patent_app_country] => US [patent_app_date] => 1995-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5479 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652234.pdf [firstpage_image] =>[orig_patent_app_number] => 513803 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/513803
3-(7-oxo-1-aza-4-oxabicyclo[3.2.0]hept-3-yl)alanine derivative as antitumor agent Oct 5, 1995 Issued
Array ( [id] => 3695854 [patent_doc_number] => 05618830 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease' [patent_app_type] => 1 [patent_app_number] => 8/536294 [patent_app_country] => US [patent_app_date] => 1995-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7037 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618830.pdf [firstpage_image] =>[orig_patent_app_number] => 536294 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/536294
Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease Sep 28, 1995 Issued
08/537170 METHOD OF TREATING CANCER BY CONJUNCTIVE THERAPY WITH 2'-HALOMETHYLIDENE DERIVATIVES AND A S-PHASE OR M-PHASE SPECIFIC ANTINEOPLASTIC AGENT Sep 27, 1995 Abandoned
08/533424 1,2,4-BENZOTRIAZINE OXIDES FORMULATIONS Sep 24, 1995 Abandoned
Menu